Annieke C.G. van Baar

Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study

Annieke C.G. van Baar, F. Holleman, Laurent Crenier et al. · Gut · 2019 · 192 citations · Full text

Inhibitor development and mortality in non‐severe hemophilia A

Corien L. Eckhardt, J.I. Loomans, Alice S. van Velzen et al. · Journal of Thrombosis and Haemostasis · 2015 · 74 citations · Full text

Endoscopic duodenal mucosal resurfacing improves glycaemic and hepatic indices in type 2 diabetes: 6-month multicentre results

Annieke C.G. van Baar, Ulrich Beuers, Kari E. Wong et al. · JHEP Reports · 2019 · 50 citations · Full text

Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study

Annieke C.G. van Baar, Suzanne Meiring, Paul Smeele et al. · Gastrointestinal Endoscopy · 2020 · 44 citations · Full text

Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study)

Annieke C.G. van Baar, Jacques Devière, David Hopkins et al. · Diabetes Research and Clinical Practice · 2022 · 38 citations · Full text